LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
LivaNova PLC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$78.14+0.56 (+0.72%)
Close on Oct 19, 2026
- Market cap
- $4.40B
- P/E (TTM)
- 23.1
- Dividend yield
- –
LivaNova statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Electromedical & Electrotherapeutic Apparatus companies for comparison
Valuation
| Measure | LivaNova | Industry median |
|---|---|---|
| Market Cap | $4.31B | $230.55M |
| Enterprise Value | $4.08B | $202.97M |
| PE Ratio | 23.05 | 31.60 |
| PS Ratio | 2.93 | 3.10 |
| PB Ratio | 3.25 | 3.04 |
| P/TBV Ratio | 13.08 | 4.43 |
| P/FCF Ratio | 29.03 | 27.30 |
| P/OCF Ratio | 17.27 | 22.47 |
Enterprise value
| Measure | LivaNova | Industry median |
|---|---|---|
| EV / Sales | 2.77 | 2.91 |
| EV / EBITDA | 21.76 | 19.74 |
| EV / EBIT | 21.76 | 24.80 |
| EV / FCF | 27.52 | 27.89 |
Income (trailing twelve months)
| Measure | LivaNova | Industry median |
|---|---|---|
| Revenue | $1.47B | $102.39M |
| Gross Profit | $1.00B | $60.36M |
| Operating Income | $187.55M | -$4.31M |
| Pretax Income | $107.51M | -$2.37M |
| Net Income | $188.55M | -$6.57M |
| EBITDA | $187.55M | -$1.98M |
| EPS (Diluted) | $3.39 | -$0.08 |
Margins
| Measure | LivaNova | Industry median |
|---|---|---|
| Gross Margin | 68.1% | 55.2% |
| Operating Margin | 12.7% | -6.04% |
| Pretax Margin | 7.31% | -4.11% |
| Profit Margin | 12.8% | -10.5% |
| EBITDA Margin | 12.7% | -2.67% |
| FCF Margin | 10.1% | 0.02% |
Returns
| Measure | LivaNova | Industry median |
|---|---|---|
| Return on Equity (ROE) | 15.4% | -18.2% |
| Return on Assets (ROA) | 7.33% | -13.3% |
| Return on Invested Capital (ROIC) | 18.2% | -3.69% |
| Return on Capital Employed (ROCE) | 9.70% | -9.07% |
Growth
| Measure | LivaNova | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 12.4% | 8.85% |
| FCF Growth (YoY) | -8.51% | 9.68% |
| Revenue Growth (3Y CAGR) | 10.8% | 7.08% |
| Revenue Growth (5Y CAGR) | 8.24% | 11.8% |
Balance sheet
| Measure | LivaNova | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $516.62M | $36.66M |
| Total Debt | $293.49M | $97.65M |
| Net Cash (Debt) | $223.13M | $3.92M |
| Net Cash Per Share | $4.05 | $0.28 |
| Equity (Book Value) | $1.33B | $55.33M |
| Book Value Per Share | $24.06 | $2.87 |
| Tangible Book Value | $329.18M | $10.79M |
| Working Capital | $318.04M | $56.72M |
Financial position
| Measure | LivaNova | Industry median |
|---|---|---|
| Current Ratio | 1.45 | 2.48 |
| Quick Ratio | 1.06 | 1.53 |
| Debt / Equity | 0.22 | 0.41 |
| Debt / EBITDA | 1.56 | 2.40 |
| Debt / FCF | 1.98 | 3.49 |
| Net Debt / EBITDA | -1.19 | 1.53 |
| Interest Coverage | 5.04 | -1.85 |
Cash flow (trailing twelve months)
| Measure | LivaNova | Industry median |
|---|---|---|
| Operating Cash Flow | $249.26M | -$566.22K |
| Capital Expenditures | -$100.95M | -$3.69M |
| Free Cash Flow | $148.31M | -$696.00K |
| FCF Per Share | $2.69 | -$0.02 |
Efficiency
| Measure | LivaNova | Industry median |
|---|---|---|
| Asset Turnover | 0.57 | 0.58 |
| Inventory Turnover | 2.78 | 2.21 |
| Revenue Per Employee | $445.92K | $322.92K |
| Profits Per Employee | $57.14K | -$51.88K |
| Employee Count | 3,300 | 185 |
Dividends and yields
| Measure | LivaNova | Industry median |
|---|---|---|
| Earnings Yield | 4.38% | -6.88% |
| FCF Yield | 3.44% | -0.45% |
Shares
| Measure | LivaNova | Industry median |
|---|---|---|
| Shares Outstanding | 55,093,500 | 44,302,700 |
| Shares Change (YoY) | 1.62% | 3.36% |
| Shares Change (QoQ) | 0.27% | 0.27% |
| Float | 54,829,100 | 37,462,700 |
| Shares Held by Insiders | 0.48% | 10.5% |
| Shares Held by Institutions | 107.8% | 63.5% |
Taxes
| Measure | LivaNova | Industry median |
|---|---|---|
| Income Tax | -$82.03M | $1.52M |
| Effective Tax Rate | -76.3% | 18.5% |
Scores
| Measure | LivaNova | Industry median |
|---|---|---|
| Graham Number | $42.84 | $35.97 |
| Graham Upside | -45.2% | -57.0% |
| Altman Z-Score | 2.36 | 1.95 |
| Piotroski F-Score | 5 | 5 |
Calculated by StockData from LivaNova's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.